Details of Drug-Drug Interaction
| Drug General Information (ID: DDI3LQREVU) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Norethisterone | Drug Info | Sugammadex | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Contraceptive Agents | Anesthetics | |||||||
| Structure | |||||||||
| Mechanism of Norethisterone-Sugammadex Interaction (Severity Level: Major) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Attenuated pharmacological effects (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Norethisterone | Sugammadex | |||||||
| Mechanism | Hormonal contraceptives | Reduce the therapeutic efficacy of hormonal contraceptives | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacodynamics | ||||||||
| Factor Description | Reduced pharmacological effects leading to insufficient efficacy and/or treatment failure. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Female patients of reproductive potential receiving hormonal contraceptives (whether oral or non-oral) should use an additional, nonhormonal contraceptive method or backup method of contraception (e.g., condoms and spermicides) for 7 days after sugammadex administration. | ||||||||
